antibody

Documents about antibody

• Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma#880736ClinicalTrials.gov
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV#886687ClinicalTrials.gov
• A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients#889313ClinicalTrials.gov
• Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures.#9472PubMed
• Targeted inhibition of ITK activity with anti-CD3 antibody-modified calcium silicate nanoparticles loaded with novel 7H-Pyrrolo[2,3-d]pyrimidine derivatives for treating aplastic anemia.#159876NCBI PubMed Central
• Recombinant proteins expressed in Mycolicibacterium smegmatis enhance antibody-based detection of bovine tuberculosis#171606HAL (France)
• Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study#272416ClinicalTrials.gov
• The journey of targeted drug conjugates in solid tumors: moving beyond antibody drug conjugates#273690Figshare
• First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies#350935IRIS
• Development, characterization and evaluation of 5-fluorouracil loaded gold nanoparticles conjugated with cd133 antibody targeting positive-survivin colorectal cancer stem cells#373029USM Repository
• Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)#377367ClinicalTrials.gov
• Activity of CD37-ADCs in rituximab-resistant and CD20-deficient Raji lymphoma models#396761RepOD Dataverse OAI Archive
• Cell Surface Deazaflavin-Diazirine Energy-Transfer (DarT) Photoproximity Labeling Using Antibody Conjugates#475544edoc-Server
• ATR 1072 in Participants With PRKAG2 Syndrome#804100ClinicalTrials.gov
• A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy#804361ClinicalTrials.gov
• Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology#807124ClinicalTrials.gov
• Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome#811032ClinicalTrials.gov
• Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders#811214ClinicalTrials.gov
• Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.#830779ClinicalTrials.gov
• Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease#836485ClinicalTrials.gov
• Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection#842546ClinicalTrials.gov
• High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors#846802ClinicalTrials.gov
• Folfox-B Study for Patients With Colorectal Liver Metastases#848755ClinicalTrials.gov
• Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody#849116ClinicalTrials.gov
• Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.#853469ClinicalTrials.gov
• Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma#867718ClinicalTrials.gov
• A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)#868376ClinicalTrials.gov
• A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World#884801ClinicalTrials.gov
• Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.#889295ClinicalTrials.gov
• Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial#892785ClinicalTrials.gov
• Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy#195315ClinicalTrials.gov
• Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer’s Disease Model#231289Europe PMC
• Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis.#281627Repisalud
• CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery#307322ClinicalTrials.gov
• Exploring gefitinib to enhance endocytosis of antibodies and nucleic acid aptamers targeting EGFR in glioblastoma#308232HAL (France)
• Advancing SARS-CoV-2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure#342289KOASAS: KAIST Open Access Self-Archiving System
• Origin, content and activity of diastase in honey analyzed by LC-MS/MS and one-step double antibody sandwich ELISA#357405HAL (France)
• Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus#405217ClinicalTrials.gov
• A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau#436219HAL (France)
• Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer#485136Europe PMC
• Evaluation of a novel biplex rapid diagnostic test for antibody responses to Loa loa and Onchocerca volvulus infections in Congo (2022-2023)#641127DataSuds Dataverse OAI Archive
• Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases#676952HAL (France)
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer#807015ClinicalTrials.gov
• A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors#811269ClinicalTrials.gov
• A Safety Study in Patients With Chronic Lymphocytic Leukemia#812654ClinicalTrials.gov
• Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents#828063ClinicalTrials.gov
• Hematological Response in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5 Antibody: an External Control Arm Study for Iptacopan Use in Anti-C5 naïve Patients#829924ClinicalTrials.gov
• Evaluation of InnoLIA HTLV I/II Score#839268ClinicalTrials.gov
• Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease#842503ClinicalTrials.gov
• Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma#851165ClinicalTrials.gov